The observed relationships between PFAS levels and COPD risk in our study can be explained by underlying biological mechanisms, including inflammation (44), oxidative stress (45), and PFAS interactions with albumin and lung tissues (46). This evidence concerns the gene ALB and chronic obstructive pulmonary disease.